As we have written on this blog several times this year, a growing number of studies have suggested a link between problems with Depakote and lower I.Q., as well as other developmental delays, autism and potential birth defects/malformations. In the face of this mounting evidence, the… Read More
By Harvey Kirk
May 7, 2013 | No Comments
The Depakote lawyers at Saiontz & Kirk, P.A. are reviewing lawsuits for families of children diagnosed with autism, developmental delay or severe birth defects following use of the epilepsy drug during pregnancy. This month, another study has been published providing further support for the link between… Read More
By Harvey Kirk
April 25, 2013 | 1 Comment
The amount of evidence is growing in support of Depakote lawsuits that allege use of the antiseizure drug during pregnancy increases the risk that children will suffer developmental delays, lower I.Q., autism and other cognitive problems. (more…) Read More
By Harvey Kirk
March 27, 2013 | 2 Comments
According to allegations raised in a number of recent Depakote lawsuits being pursued for children born with spina bifida and other congential malformations, Abbott Laboratories has known or should have known about the risks associated with their anti-epileptic medication for years, yet failed to warn women… Read More
By Austin Kirk
May 13, 2011 | No Comments
The lawyers at Saiontz & Kirk, P.A. have been reviewing potential Depakote lawsuits for children born to mothers who were given the epilepsy drug during pregnancy, as the medication has been linked to major birth defects like spina bifida, cleft palate, malformations and other problems. … Read More
By Austin Kirk
July 8, 2010 | 1 Comment
The epilepsy drug Depakote has been linked to an increased risk of mental retardation and birth injuries when taken during pregnancy. According to recent reports, the risk of Depakote birth defects could be significantly greater when compared to the risks associated with alternative anticonvulsants. (more…) Read More
By Austin Kirk
May 15, 2007 | 1 Comment